DK106897A - Fremgangsmåde til fremstilling af urinstofderivater - Google Patents

Fremgangsmåde til fremstilling af urinstofderivater Download PDF

Info

Publication number
DK106897A
DK106897A DK106897A DK106897A DK106897A DK 106897 A DK106897 A DK 106897A DK 106897 A DK106897 A DK 106897A DK 106897 A DK106897 A DK 106897A DK 106897 A DK106897 A DK 106897A
Authority
DK
Denmark
Prior art keywords
preparation
urea derivatives
urea
derivatives
Prior art date
Application number
DK106897A
Other languages
English (en)
Other versions
DK172732B1 (da
Inventor
Ronald D Dennis
Terence M Dolak
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK106897A publication Critical patent/DK106897A/da
Application granted granted Critical
Publication of DK172732B1 publication Critical patent/DK172732B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK199701068A 1982-09-13 1997-09-17 Fremgangsmåde til fremstilling af urinstofderivater DK172732B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/417,794 US4463176A (en) 1982-09-13 1982-09-13 Process for resolution of optical isomers
US41779482 1982-09-13

Publications (2)

Publication Number Publication Date
DK106897A true DK106897A (da) 1997-09-17
DK172732B1 DK172732B1 (da) 1999-06-21

Family

ID=23655420

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198304164A DK172720B1 (da) 1982-09-13 1983-09-13 Fremgangsmåde til opspaltning af en racemisk modifikation af beta-adrenerge aryl- eller heteroarylpropanolaminer i de tilsv
DK199701068A DK172732B1 (da) 1982-09-13 1997-09-17 Fremgangsmåde til fremstilling af urinstofderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK198304164A DK172720B1 (da) 1982-09-13 1983-09-13 Fremgangsmåde til opspaltning af en racemisk modifikation af beta-adrenerge aryl- eller heteroarylpropanolaminer i de tilsv

Country Status (29)

Country Link
US (1) US4463176A (da)
JP (2) JPS5980616A (da)
KR (1) KR890000616B1 (da)
AT (1) AT385032B (da)
AU (1) AU573535B2 (da)
BE (1) BE897737A (da)
CA (1) CA1250290A (da)
CH (1) CH660732A5 (da)
CY (1) CY1543A (da)
DE (1) DE3333025A1 (da)
DK (2) DK172720B1 (da)
ES (1) ES525543A0 (da)
FI (1) FI83767C (da)
FR (1) FR2540490B1 (da)
GB (2) GB2127020B (da)
GR (1) GR81546B (da)
HK (1) HK97990A (da)
HU (1) HU193183B (da)
IE (1) IE55650B1 (da)
IL (1) IL69708A (da)
IT (1) IT1170213B (da)
LU (1) LU84998A1 (da)
NL (1) NL8303154A (da)
NO (1) NO159267C (da)
NZ (1) NZ205554A (da)
PT (1) PT77331B (da)
SE (2) SE452608B (da)
YU (1) YU43327B (da)
ZA (1) ZA836795B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma
US5364872A (en) * 1984-04-16 1994-11-15 Yamanouchi Pharmaceutical Co., Ltd. Dihydropyridine-3,5-dicarboxylic acid ester derivatives
US5039801A (en) * 1985-12-20 1991-08-13 The United States Of America As Represented By The Department Of Health & Human Services Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines
US4797498A (en) * 1986-07-18 1989-01-10 Pennwalt Corporation Flavonoxypropanolamines and esters of flavonoxypropanolamines as antiarrhythmic agents
EP0305496A4 (en) * 1987-03-17 1989-07-11 Insite Vision Inc TIMOLOL DERIVATIVES.
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
US4806660A (en) * 1987-11-06 1989-02-21 Pennwalt Corporation Aurone oxypropanolamines
JP2801768B2 (ja) * 1990-11-17 1998-09-21 日東電工株式会社 新規な光学活性メトプロロール・酒石酸誘導体塩及びその製法、並びにこの塩を用いる光学活性メトプロロールの製法
US5082970A (en) * 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
KR100332399B1 (ko) * 1999-02-22 2002-04-13 김경호 메토프롤롤 라세미체로부터 메토프롤롤 에난티오머의 제조방법
BE1012622A3 (fr) 1999-04-21 2001-01-09 Solvay Procede pour la separation d'enantiomeres et reactif enantiopur.
US7138538B2 (en) * 2000-04-14 2006-11-21 Solvay (Societe Anonyme) Process for the separation of enantiomers and enantiopure reagent
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US234595A (en) * 1880-11-16 Juan f
GB1211589A (en) * 1968-08-06 1970-11-11 Ici Ltd Enantiomer isolation process
BE786963A (fr) * 1971-07-30 1973-01-29 Degussa Procede pour le dedoublement racemique de d,1-phenylpropanolamine
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
JPS5770884A (en) * 1980-10-21 1982-05-01 Kyowa Hakko Kogyo Co Ltd Novel piperidine derivative and its preparation
FI76551C (fi) * 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.

Also Published As

Publication number Publication date
GB8324536D0 (en) 1983-10-12
AU573535B2 (en) 1988-06-16
DK416483A (da) 1984-03-14
PT77331B (en) 1986-08-28
IL69708A (en) 1987-02-27
SE8602724L (sv) 1986-06-18
ZA836795B (en) 1984-04-25
GB2169294B (en) 1987-05-13
CA1250290A (en) 1989-02-21
YU184683A (en) 1986-02-28
FR2540490B1 (fr) 1986-09-05
DK172732B1 (da) 1999-06-21
IE55650B1 (en) 1990-12-05
NZ205554A (en) 1987-09-30
AU1908183A (en) 1984-03-22
NO159267C (no) 1988-12-14
US4463176A (en) 1984-07-31
GB2169294A (en) 1986-07-09
NO159267B (no) 1988-09-05
FI833270A0 (fi) 1983-09-13
GB8604515D0 (en) 1986-04-03
AT385032B (de) 1988-02-10
IL69708A0 (en) 1983-12-30
DK172720B1 (da) 1999-06-14
SE8304887L (sv) 1984-03-14
CY1543A (en) 1991-03-22
FR2540490A1 (fr) 1984-08-10
SE452608B (sv) 1987-12-07
SE8602724D0 (sv) 1986-06-18
DE3333025A1 (de) 1984-03-29
LU84998A1 (fr) 1984-04-24
GB2127020B (en) 1987-05-07
HU193183B (en) 1987-08-28
JPS5980616A (ja) 1984-05-10
ES8504104A1 (es) 1985-04-16
YU43327B (en) 1989-06-30
SE8304887D0 (sv) 1983-09-12
PT77331A (en) 1983-10-01
BE897737A (fr) 1984-03-12
NL8303154A (nl) 1984-04-02
FI833270L (fi) 1984-03-14
HK97990A (en) 1990-11-30
FI83767B (fi) 1991-05-15
NO833254L (no) 1984-03-14
KR890000616B1 (ko) 1989-03-22
ATA326383A (de) 1987-07-15
DK416483D0 (da) 1983-09-13
ES525543A0 (es) 1985-04-16
DE3333025C2 (da) 1992-01-23
JPH0414086B2 (da) 1992-03-11
IE832134L (en) 1984-03-13
JP2759184B2 (ja) 1998-05-28
IT1170213B (it) 1987-06-03
FI83767C (fi) 1991-08-26
GR81546B (da) 1984-12-11
KR840005998A (ko) 1984-11-21
JPH0859597A (ja) 1996-03-05
IT8322852A0 (it) 1983-09-12
CH660732A5 (fr) 1987-06-15
GB2127020A (en) 1984-04-04

Similar Documents

Publication Publication Date Title
DK106897A (da) Fremgangsmåde til fremstilling af urinstofderivater
DK301383D0 (da) Fremgangsmade til fremstilling af imidazolderivater
DK513883A (da) Fremgangsmaade til fremstilling af aminderivater
DK95483A (da) Fremgangsmaade til fremstilling af tetrahydropyranderivater
DK241883D0 (da) Fremgangsmade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK372283A (da) Fremgangsmaade til fremstilling af desoxyuridinderivater
DK155984D0 (da) Fremgangsmade til fremstilling af thiadiazolderivater
DK63683D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK53483D0 (da) Fremgangsmade til fremstilling af guanidinderivater
DK323083A (da) Fremgangsmaade til fremstilling af 19-thio-androstanderivater
DK435483D0 (da) Fremgangsmade til fremstilling af fenylcyklobutylderivater
DK427083D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK140584A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK261883A (da) Fremgangsmaade til fremstilling af prostaglandin-d-derivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK317283D0 (da) Fremgangsmade til fremstilling af thiadiazolderivater
DK426683D0 (da) Fremgangsmade til fremstilling af oxacephalosporinderivater
DK340483D0 (da) Fremgangsmade til fremstilling af fluoralkylerede carbapenemderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK482983A (da) Fremgangsmaade til fremstilling af phenylderivater
DK542383D0 (da) Fremgangsmade til fremstilling af acridanonderivater
DK164283D0 (da) Fremgangsmade til fremstilling af benzimidazolderivater
DK96383D0 (da) Fremgangsmade til fremstilling af 3-azetidinylaetyl-1-fenyl-2-imidazolidinonderivater
DK88283D0 (da) Fremgangsmade til fremstilling af triazolderivater
DK159283A (da) Fremgangsmaade til fremstilling af indolderivater

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired